SCHEMBL9037713

SCHEMBL9037713

C[C@H]1NC(=O)N[C@@H]1CCCCCC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 8/20 1.00
RIN1 Q13671 8/20 1.00
PPARG P37231 5/20 1.00
NR2E3 Q9Y5X4 3/20 1.00
NCOR2 Q9Y618 2/20 1.00
IDE P14735 2/20 1.00
TDP1 Q9NUW8 11/20 0.97
ALDH1A1 P00352 5/20 0.58
NSD2 O96028 3/20 0.58
MAPK10 P53779 2/20 0.58
MAPK1 P28482 2/20 0.58
HSD17B10 Q99714 2/20 0.58
L3MBTL1 Q9Y468 3/20 0.57
HPGD P15428 1/20 0.57
TAAR1 Q96RJ0 1/20 0.57
LMNA P02545 3/20 0.56
SMN1; SMN2 Q16637 1/20 0.51
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13079427 1.00 ABL1 (1.00) ABL1RIN1PPARGNR2E3NCOR2
SCHEMBL14956497 1.00 ABL1 (1.00) ABL1RIN1PPARGNR2E3NCOR2
SCHEMBL143997 1.00 ABL1 (1.00) ABL1RIN1PPARGNR2E3NCOR2
SCHEMBL13049464 1.00 ABL1 (1.00) ABL1RIN1PPARGNR2E3NCOR2
SCHEMBL143996 1.00 ABL1 (1.00) ABL1RIN1PPARGNR2E3NCOR2
Ammonia Solution, Strong SCHEMBL5943165 0.98 ABL1 (0.97) ABL1RIN1PPARGNR2E3NCOR2
SCHEMBL19739348 0.98 ABL1 (0.97) ABL1RIN1PPARGNR2E3NCOR2
SCHEMBL9601528 0.98 TDP1 (1.00) ABL1RIN1PPARGNR2E3NCOR2
SCHEMBL381614 0.94 ABL1 (0.88) ABL1RIN1PPARGNR2E3NCOR2
Thiosulfuric Acid SCHEMBL6499597 0.91 ABL1 (0.83) ABL1RIN1PPARGNR2E3NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-8256785-A None JP disclosed
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
US-11324827-B2 Multifunctionalized polyethylene glycol derivative and preparation method therefor XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2022-05-10 US disclosed
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2020-05-26 US disclosed
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2019-10-08 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed
US-10183965-B2 Cofactor analogues for methyltransferases KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2019-01-22 US disclosed
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2018-08-02 US disclosed
EP-3315531-A1 8-ARM POLYETHYLENE GLYCOL DERIVATIVE, MANUFACTURING METHOD AND MODIFIED BIO-RELATED SUBSTANCE THEREBY Xiamen Sinopeg Biotech Co., Ltd. (CN) 2018-05-02 EP disclosed
US-20170312363-A1 MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2017-11-02 US disclosed
US-20170283453-A1 COFACTOR ANALOGUES FOR METHYLTRANSFERASES KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2017-10-05 US disclosed
EP-3186266-A1 S-ADENOSYL-L-CYSTEINE ANALOGUES AS COFACTORS FOR METHYLTRANSFERASES Katholieke Universiteit Leuven (BE) 2017-07-05 EP disclosed
WO-2016030546-A1 S-ADENOSYL-L-CYSTEINE ANALOGUES AS COFACTORS FOR METHYLTRANSFERASES KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2016-03-03 WO disclosed
JP-H08256785-A PRODUCTION OF D-DETHIOBIOTIN F HOFFMANN LA ROCHE AG 1996-10-08 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof MRPL38, ALG8, MRPS18A ABL1 4088/4885RIN1 1704/4885PPARG 3105/4885
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof MRPL38, ALG8, COG8 ABL1 4168/4885RIN1 1597/4885PPARG 3829/4885
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF MRPL38, CXCL8, ALG8 ABL1 4257/4885RIN1 2298/4885PPARG 3625/4885
US-10183965-B2 Cofactor analogues for methyltransferases BHMT, BHMT2, NNMT ABL1 2910/4885RIN1 3098/4885PPARG 3419/4885
US-11324827-B2 Multifunctionalized polyethylene glycol derivative and preparation method therefor HDGF, F11, F12 ABL1 3984/4885RIN1 813/4885PPARG 2792/4885
US-20170283453-A1 COFACTOR ANALOGUES FOR METHYLTRANSFERASES BHMT, BHMT2, NNMT ABL1 2876/4885RIN1 3128/4885PPARG 3414/4885
US-20170312363-A1 MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR HDGF, F11, F12 ABL1 3984/4885RIN1 813/4885PPARG 2792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.